Schrodinger (NASDAQ:SDGR – Free Report) had its price objective lowered by KeyCorp from $28.00 to $25.00 in a research note published on Thursday,Benzinga reports. KeyCorp currently has an overweight rating on the stock.
Other research analysts have also issued research reports about the stock. Bank of America upgraded shares of Schrodinger from a “neutral” rating to a “buy” rating and set a $24.00 price target on the stock in a research note on Monday, December 15th. The Goldman Sachs Group began coverage on shares of Schrodinger in a research report on Monday, September 29th. They set a “neutral” rating and a $19.00 target price on the stock. UBS Group assumed coverage on Schrodinger in a report on Wednesday. They set a “neutral” rating and a $18.00 target price on the stock. Wall Street Zen raised Schrodinger from a “sell” rating to a “hold” rating in a report on Saturday, October 25th. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of Schrodinger in a research note on Tuesday, October 14th. Six equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $24.33.
View Our Latest Stock Analysis on Schrodinger
Schrodinger Price Performance
Schrodinger (NASDAQ:SDGR – Get Free Report) last announced its quarterly earnings results on Wednesday, November 5th. The company reported ($0.45) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.72) by $0.27. Schrodinger had a negative return on equity of 48.24% and a negative net margin of 68.49%.The business had revenue of $54.32 million during the quarter, compared to analyst estimates of $50.51 million. During the same period in the previous year, the company earned ($0.87) EPS. The firm’s revenue was up 53.9% on a year-over-year basis. On average, equities analysts anticipate that Schrodinger will post -2.37 EPS for the current year.
Insider Activity at Schrodinger
In related news, insider Margaret Dugan sold 1,395 shares of the business’s stock in a transaction dated Thursday, October 16th. The stock was sold at an average price of $21.07, for a total transaction of $29,392.65. Following the completion of the transaction, the insider owned 24,574 shares of the company’s stock, valued at approximately $517,774.18. The trade was a 5.37% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 21.00% of the company’s stock.
Institutional Inflows and Outflows
Several institutional investors have recently added to or reduced their stakes in the business. Farther Finance Advisors LLC boosted its position in shares of Schrodinger by 347.4% in the second quarter. Farther Finance Advisors LLC now owns 1,284 shares of the company’s stock valued at $26,000 after acquiring an additional 997 shares during the period. Bayforest Capital Ltd acquired a new position in Schrodinger during the 2nd quarter valued at $30,000. Aster Capital Management DIFC Ltd boosted its holdings in Schrodinger by 212.4% in the 3rd quarter. Aster Capital Management DIFC Ltd now owns 1,943 shares of the company’s stock valued at $39,000 after purchasing an additional 1,321 shares during the period. State of Wyoming acquired a new stake in Schrodinger in the 2nd quarter worth $39,000. Finally, SBI Securities Co. Ltd. increased its holdings in shares of Schrodinger by 110.4% during the 3rd quarter. SBI Securities Co. Ltd. now owns 2,127 shares of the company’s stock worth $43,000 after purchasing an additional 1,116 shares during the period. 79.05% of the stock is owned by institutional investors.
More Schrodinger News
Here are the key news stories impacting Schrodinger this week:
- Positive Sentiment: Schrödinger announced a partnership with Eli Lilly to integrate Lilly’s TuneLab AI drug‑discovery platform into Schrödinger’s LiveDesign enterprise informatics platform, making TuneLab a priority interface for participating biotech customers — this strengthens LiveDesign’s product value and could accelerate commercial deals or usage-based revenue. Business Wire
- Positive Sentiment: Media coverage highlights Lilly’s broader pact (including Revvity) to provide AI-driven drug‑discovery capabilities — public attention and third‑party ecosystem involvement can increase demand for Schrödinger’s software interfaces and partnerships. MSN
- Neutral Sentiment: TD Cowen reduced its price target from $33 to $24 but maintained a “buy” rating — this narrows analyst-implied upside while still signaling confidence in long‑term growth potential. TickerReport
- Neutral Sentiment: KeyCorp lowered its target from $28 to $25 and kept an “overweight” rating — another mixed signal: lower near‑term targets but continued positive stance on the business model. TickerReport
- Neutral Sentiment: Market commentary comparing Schrodinger with peers appears, but offers limited incremental near‑term impact; useful for relative valuation context. American Banking News
- Negative Sentiment: UBS initiated coverage with a “hold” and a $18 price target (below recent levels), which could exert downward pressure or limit buying interest until catalysts justify re‑rating. MSN
Schrodinger Company Profile
Schrödinger, Inc is a life sciences and materials discovery company that specializes in the application of physics-based computational platforms to accelerate drug discovery and advanced materials design. Founded in 1990 by Professor Richard A. Friesner, Schrödinger has developed a suite of proprietary software tools—such as Maestro for molecular modeling, Glide for molecular docking and Jaguar for quantum chemistry calculations—that enable scientists to predict molecular behavior with high accuracy.
Featured Articles
- Five stocks we like better than Schrodinger
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- A U.S. “birthright” claim worth trillions – activated quietly
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
- First Time Since 2007: All Warnings Active
- How the Rich Retire
Receive News & Ratings for Schrodinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Schrodinger and related companies with MarketBeat.com's FREE daily email newsletter.
